Variable | Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
Sex | ||||
 Female vs. male | 0.90 (0.84–0.97) | 0.004 | 0.88 (0.82–0.95) |  < 0.001 |
Age (years) | ||||
 40–49 vs. < 40 | 0.79 (0.57–1.08) | 0.14 | 0.89 (0.65–1.22) | 0.46 |
 50–59 vs. < 40 | 0.93 (0.69–1.26) | 0.63 | 1.05 (0.77–1.42) | 0.76 |
 60–69 vs. < 40 | 1.15 (0.85–1.56) | 0.36 | 1.31 (0.97–1.77) | 0.08 |
 70–79 vs. < 40 | 1.64 (1.20–2.22) | 0.002 | 1.87 (1.37–2.53) |  < 0.001 |
  ≥ 80 vs. < 40 | 2.49 (1.65–3.75) |  < 0.001 | 2.59 (1.72–3.91) |  < 0.001 |
Tumor stage | ||||
 II vs. 0/I | 1.54 (1.27–1.85) |  < 0.001 | 1.56 (1.29–1.88) |  < 0.001 |
 III vs. 0/I | 2.54 (2.11–3.07) |  < 0.001 | 2.60 (2.16–3.13) |  < 0.001 |
 IV vs. 0/I | 2.37 (1.87–3.01) |  < 0.001 | 2.36 (1.86–3.00) |  < 0.001 |
Surgical approach | ||||
 Thoracoabdominal vs. transthoracic | 1.15 (1.06–1.25) | 0.001 | 1.16 (1.07–1.26) |  < 0.001 |
 Transabdominal vs. transthoracic | 1.38 (1.21–1.56) |  < 0.001 | 1.31 (1.16–1.49) |  < 0.001 |